Balaxi Pharmaceuticals Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 70.20 | 108.14 | 101.29 | 86.87 | 45.63 |
| Operating profit | 5.24 | 16.82 | 17.26 | 18.89 | 6.46 |
| Interest | 1.54 | 0.46 | 0.06 | 0.01 | - |
| Gross profit | 6.09 | 22.97 | 19.95 | 20.68 | 9.27 |
| EPS (Rs) | 0.67 | 3.19 | 2.93 | 3.03 | 1.30 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 2.40 | 6.60 | 2.75 | 1.81 | 2.81 |
| Stock adjustment | - | - | - | - | - |
| Raw material | 56.49 | 82.10 | 76.92 | 63.33 | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 4.38 | 4.84 | 2.90 | 1.95 | 1.76 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | 4.09 | 4.38 | 4.21 | 2.71 | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | - | - | - | - | 37.41 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.51 | 0.52 | 0.25 | 0.09 | 0.01 |
| Taxation | 1.93 | 6.23 | 5.03 | 5.46 | 2.77 |
| Net profit / loss | 3.65 | 16.22 | 14.67 | 15.13 | 6.50 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 10.90 | 10.18 | 10.00 | 10.00 | 10.00 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 7.46 | 15.55 | 17.04 | 21.74 | 14.16 |
| GPM (%) | 8.39 | 20.02 | 19.17 | 23.32 | 19.14 |
| NPM (%) | 5.03 | 14.14 | 14.10 | 17.07 | 13.41 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis